Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2008-06-18Clinical Trial Update: PS-Omega3 Supplementation to Attention Deficit Hyperactivity Disorder (ADHD) Children [Phase 2]
This document provides an update on a Phase 2 clinical trial of PS-Omega3 supplementation in children with ADHD. The sponsor is Tel-Aviv Sou…
-
CLINICAL_TRIALS trial_result · 2008-06-06Clinical Trial Update: Further Studies of Attention Deficit Disorder - Residual Type (RT) [Phase 3]
A Phase 3 clinical trial investigating treatments for attention-deficit/hyperactivity disorder residual type has completed.
-
FDA approval · 2008-05-23FDA Approved: DEXEDRINE SPANSULE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Dexedrine Spansule (dextroamphetamine sulfate) from Amneal Pharmaceuticals LLC.
-
FDA approval · 2008-05-07FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Strattera (atomoxetine hydrochloride) from Eli Lilly and Company to update or expand its lab…
-
CLINICAL_TRIALS trial_result · 2008-05-06Clinical Trial Update: Effects of L-Theanine in Boys With ADHD [Phase 2]
Phase 2 clinical trial assessing L-Theanine in boys with ADHD has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Basic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD) [Phase 4]
The University of Illinois at Chicago completed a Phase 4 basic and clinical research study on attention-deficit/hyperactivity disorder. The…
-
CLINICAL_TRIALS trial_result · 2008-03-10Clinical Trial Update: The COMACS Study: A Comparison of Methylphenidates in an Analog Classroom Setting [Phase 4]
An update on the COMACS study reports the completion of a Phase 4 trial comparing methylphenidate formulations in an analog classroom settin…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Assessment of Attentional Functioning in Children With HIV-1 Infection
This clinical trial update reports a completed study assessing attentional functioning in children with HIV-1 infection.
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Study of Attention Deficit/Hyperactivity Disorder Using Transcranial Magnetic Stimulation
A clinical trial evaluating transcranial magnetic stimulation as a treatment for attention-deficit/hyperactivity disorder has completed. The…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Genetic Aspects of Neurologic and Psychiatric Disorders
A National Institute of Mental Health clinical trial update reports completed research on the genetic aspects of several neurologic and psyc…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Study of Children at Risk for Disruptive Behavior Disorders
A completed clinical trial update from the National Institute of Mental Health evaluating children at risk for disruptive behavior disorders…
-
CLINICAL_TRIALS trial_result · 2008-02-21Clinical Trial Update: Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD [Phase 3]
A Phase 3, placebo-controlled, double-blind trial in adults with ADHD evaluating extended-release methylphenidate has completed.
-
FDA approval · 2008-02-06FDA Approved: DEXTROAMPHETAMINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for dextroamphetamine sulfate, a generic stimulant indicated for atte…
-
FDA approval · 2008-02-05FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
The FDA approved a supplemental application for the Methylphenidate Transdermal System (methylphenidate patch) from Padagis US LLC.
-
FDA approval · 2008-01-29FDA Approved: DEXTROAMPHETAMINE SULFATE — Original Application (Prasco Laboratories)
FDA approves a generic form of dextroamphetamine sulfate from Prasco Laboratories under an Original Application, for ADHD and narcolepsy ind…
-
FDA approval · 2008-01-16FDA Approved: DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
FDA approves a supplemental application from SpecGx LLC for a dextroamphetamine sulfate extended-release product (generic).
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder [Phase 3]
Phase 3 trial evaluating dexmethylphenidate hydrochloride extended-release capsules in children with ADHD to assess efficacy, tolerability a…
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14 [Phase 3]
A completed Phase 3 study comparing two brands of modified-release oral formulations for safety and efficacy in children aged 6 to 14 with A…
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD [Phase 3]
A Phase 3 clinical trial update from Novartis evaluating the safety and efficacy of Dexmethylphenidate in children with Attention-deficit/hy…
-
CLINICAL_TRIALS trial_result · 2007-12-21Clinical Trial Update: Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD [Phase 3]
Phase 3 safety and efficacy trial of dexmethylphenidate in children with ADHD has completed, reporting on its safety and efficacy outcomes.
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Efficacy and Safety of Once-Daily Atomoxetine Hydrochloride in Adults With ADHD Over an Extended Period of Time (6 Months) [Phase 4]
This Phase 4 trial assesses the long-term efficacy and safety of once-daily atomoxetine hydrochloride in adults with attention deficit hyper…
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Atomoxetine Treatment of Adults With ADHD and Comorbid Alcohol Abuse [Phase 4]
Completion report for a Phase 4 trial evaluating atomoxetine in adults with ADHD and comorbid alcohol use disorder.
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: Atomoxetine Versus Placebo in Children With Attention Deficit/Hyperactivity Disorder (ADHD) [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating atomoxetine versus placebo in children with attention deficit hyperactivity disorder, conducted by El…
-
CLINICAL_TRIALS trial_result · 2007-11-05Clinical Trial Update: Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories [Phase 2]
A Phase 2 safety, tolerability, and abuse-liability study of intravenous NRP104 in adults with stimulant-use histories has been completed.
-
CLINICAL_TRIALS trial_result · 2007-11-05Clinical Trial Update: Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse [Phase 1, Phase 2]
A completed Phase 1/2 study evaluating the abuse potential, safety, and likeability of NRP 104 in adults with histories of stimulant use.